JOSH'S STORY
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreAnti-mitotic drugs such as vincristine are a mainstay of current treatment regimens for multiple cancers affecting both adults and children, including medulloblastoma (MB). The clinical efficacy of these treatments is hampered by the emergence of drug-resistant clones following treatment, which can result in patient relapse. MB is a leading cause of cancer-related death in infants and children [1] with 5-year survival rate of 70%, although for patients with the most aggressive diagnosis, Group 3 (G3), this drops to 50% [2]
Grant Award – Kidscan Student Placement (2019 – 2020)
Funding Award – £2000.00
Funding Awarded to – Dr Caroline Topham
Research Location – University of Salford
Lead Researcher – Dr Caroline Topham
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreWhat a whopper of a night - Friday 20th May, our ambassador Isla's mum Jill and family hosted...
Read MoreWe want to say a huge thank you to Lee Mossop, former Captain of RFL Salford Red...
Read More